Anuh Pharma Limited has submitted a regulatory filing to both BSE Limited and National Stock Exchange of India Limited regarding an upcoming Board of Directors meeting.
The Board meeting is scheduled to be held on Friday, 30th October, 2026 at the company's registered office. The primary agenda items include:
- Consideration, approval, and taking on record of the Un-Audited Financial Results for the quarter and half year ended 30th September, 2026
- Any other business with the permission of the chair
The filing is made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additionally, the company has implemented a trading window closure in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct. The trading window for designated persons and their immediate relatives has been closed since Thursday, 1st October, 2026 and will remain closed until 48 hours after the declaration of Audited Financial Results, specifically until Sunday, 1st November, 2026 (both days inclusive).